Seeking Alpha


Send Message
View as an RSS Feed
View t.aps76's Comments BY TICKER:
Latest  |  Highest rated
  • Was Amarin's FDA Briefing A Sign Of End Times? [View article]
    I have read the briefing over and over and to me it would be ridiculous not to accept/recommend Vascepa for Anchor. The 4g dose (and to a lesser extent the 2g dose) shows strong evidence that it meets all endpoints designed by the FDA with no safety issues. In addition, the statistical difference between the EPA only studies and the EPA/DHA studies demonstrate how powerful Vascepa is as a drug compared to any other fish oil in the market. With efficacy, safety and moderately evident data showing reductions in CV risk, how could this drug not be approved for Anchor? And, god forbid, if they do vote to wait for Reduce-It data then won't the marine indication allow for Vascepa to dominate in accordance with the EPA vs DHA studies? I can see market manipulation taking this down but in the end the only place it can really go is up.
    Oct 13, 2013. 09:47 AM | Likes Like |Link to Comment
  • Guess What...Amarin Still Will Be $4-6 Billion With Anchor [View instapost]
    It is sad that you are attacking others for investment decisions and can't even back up the constant questions raised about your articles. You are trash and the earlier you learn it the faster you will regain credibility.
    Jun 26, 2013. 10:55 PM | 2 Likes Like |Link to Comment